CORE LABS INC (CLB)
(Delayed Data from NYSE)
$19.18 USD
+0.60 (3.23%)
Updated Sep 23, 2024 04:00 PM ET
After-Market: $19.18 0.00 (0.00%) 7:58 PM ET
2-Buy of 5 2
B Value B Growth C Momentum A VGM
Cash flow Statements
Fiscal Year End for Core Laboratories Inc falls in the month of December.
All data in Millions except Per Share data.
Cash Flow From Operations, Investments & Financial Activities
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
---|---|---|---|---|---|
Cash Flow From Operations, Investments & Financial Activities |
|||||
Net Income (Loss) | 37.03 | 19.66 | 20.22 | -97.07 | 94.28 |
Depreciation/Amortization & Depletion | 15.78 | 17.16 | 18.52 | 20.87 | 22.61 |
Net Change from Assets/Liabilities | -28.77 | -25.02 | -20.56 | 5.94 | -7.71 |
Net Cash from Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.15 | -0.58 |
Other Operating Activities | 0.75 | 13.16 | 18.41 | 127.99 | -19.08 |
Net Cash From Operating Activities | 24.79 | 24.96 | 36.58 | 57.87 | 89.53 |
Property & Equipment | -10.09 | -8.33 | -12.86 | -10.15 | -21.38 |
Acquisition/ Disposition of Subsidiaries | 0.00 | 0.24 | 0.87 | -0.23 | 17.77 |
Investments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Investing Activities | 3.44 | 4.23 | 1.77 | 18.22 | -2.06 |
Net Cash from Investing Activities | -6.65 | -3.86 | -10.22 | 7.85 | -5.68 |
Uses of Funds
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
---|---|---|---|---|---|
Issuance (Repurchase) of Capital Stock | -2.20 | -3.90 | 51.74 | -2.79 | -3.31 |
Issuance (Repayment) of Debt | -9.00 | -15.00 | -71.00 | -46.00 | 15.00 |
Increase (Decrease) Short-Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Payment of Dividends & Other Distributions | -1.87 | -1.85 | -1.83 | -12.45 | -97.57 |
Other Financing Activities | -5.38 | -2.62 | -1.37 | -1.77 | 0.01 |
Net Cash from Financing Activities | -18.45 | -23.38 | -22.46 | -63.01 | -85.87 |
Effect of Exchange Rate Changes | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Change In Cash & Equivalents | -0.31 | -2.28 | 3.90 | 2.71 | -2.02 |
Cash at Beginning of Period | 15.43 | 17.70 | 13.81 | 11.09 | 13.12 |
Cash at End of Period | 15.12 | 15.43 | 17.70 | 13.81 | 11.09 |
Diluted Net EPS | 0.78 | 0.42 | 0.42 | -2.20 | 2.28 |
Fiscal Year End for Core Laboratories Inc falls in the month of December.
All data in Millions except Per Share data.
Cash Flow From Operations, Investments & Financial Activities
6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | |
---|---|---|---|---|---|
Cash Flow From Operations, Investments & Financial Activities |
|||||
Net Income (Loss) | 12.68 | 3.49 | 37.03 | 34.59 | 25.37 |
Depreciation/Amortization & Depletion | 7.61 | 3.84 | 15.78 | 11.91 | 7.98 |
Net Change from Assets/Liabilities | -0.90 | -9.88 | -28.77 | -38.11 | -24.12 |
Net Cash from Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Operating Activities | 3.28 | 8.08 | 0.75 | -3.04 | -3.67 |
Net Cash From Operating Activities | 22.68 | 5.53 | 24.79 | 5.36 | 5.57 |
Property & Equipment | -5.12 | -2.46 | -10.09 | -7.42 | -4.03 |
Acquisition/ Disposition of Subsidiaries | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Investments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Investing Activities | 2.77 | 0.80 | 3.44 | 3.22 | 3.21 |
Net Cash from Investing Activities | -2.34 | -1.66 | -6.65 | -4.21 | -0.82 |
Uses of Funds
6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | |
---|---|---|---|---|---|
Issuance (Repurchase) of Capital Stock | -0.21 | -0.04 | -2.20 | -0.42 | -0.20 |
Issuance (Repayment) of Debt | -16.00 | -3.00 | -9.00 | 6.00 | 10.00 |
Increase (Decrease) Short-Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Payment of Dividends & Other Distributions | -0.94 | -0.47 | -1.87 | -1.40 | -0.93 |
Other Financing Activities | -0.61 | -0.57 | -5.38 | -4.15 | -2.84 |
Net Cash from Financing Activities | -17.76 | -4.08 | -18.45 | 0.03 | 6.02 |
Effect of Exchange Rate Changes | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Change In Cash & Equivalents | 2.58 | -0.21 | -0.31 | 1.19 | 10.78 |
Cash at Beginning of Period | 15.12 | 15.12 | 15.43 | 15.43 | 15.43 |
Cash at End of Period | 17.70 | 14.91 | 15.12 | 16.62 | 26.20 |
Diluted Net EPS | 0.19 | 0.07 | 0.06 | 0.19 | 0.48 |